(194 days)
No
The description focuses on microprocessor control, data collection, storage, and transfer, with no mention of AI or ML algorithms for analysis or decision-making.
Yes
The S7™ Elite and AUTOSET® SPIRIT™ CPAP System is indicated for the treatment of Obstructive Sleep Apnea (OSA) in adult patients, which is a medical condition. The device directly delivers therapy (Continuous Positive Airway Pressure) to the patient.
No
Explanation: The device, the S7 Elite and AUTOSET SPIRIT CPAP System, is indicated for the treatment of Obstructive Sleep Apnea (OSA). While it collects and transfers treatment data for review by a clinician (via ResLink), its primary stated purpose is therapeutic, not diagnostic. The diagnostic aspect of OSA (determining if a patient has OSA) would typically occur prior to the prescription of this treatment device.
No
The device description clearly outlines hardware components like a flow generator, patient tubing, mask, humidifier, and the ResLink device which attaches to the flow generator via a docking mechanism and uses a SmartMedia card. While software is involved (AutoScan® software for data viewing), the system is fundamentally a hardware-based CPAP system with a data collection accessory.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the treatment of Obstructive Sleep Apnea (OSA) in adult patients by providing Continuous Positive Airway Pressure (CPAP). This is a therapeutic intervention, not a diagnostic test performed on biological samples.
- Device Description: The device is a CPAP system that generates airflow to treat OSA. While it collects and stores patient data (including potentially pulse oximetry data via ResLink), this data is used for monitoring and evaluating the effectiveness of the treatment, not for diagnosing a condition based on in vitro analysis of biological specimens.
- Lack of IVD Characteristics: The description does not mention any components or processes related to analyzing biological samples (blood, urine, tissue, etc.) to diagnose a disease or condition.
The ResLink component, while collecting data, is primarily for monitoring treatment and is not performing an in vitro diagnostic test.
N/A
Intended Use / Indications for Use
The S7™ Elite and AUTOSET® SPIRIT™ CPAP System is indicated for the treatment of Obstructive Sleep Apnea (OSA) in adult patients. The optional integrated humidifier (HUMIDAIRE® 2i™) is indicated for the humidification and warming of air from the S7™ Elite or AUTOSET® SPIRIT™ flow generator device. The S7™ Elite and AUTOSET® SPIRIT™ CPAP System and HUMIDAIRE® 2i™ are for home and hospital use.
Product codes
BZD
Device Description
The S7 Elite (K013909) and AutoSet Spirit (K013843) CPAP Systems are microprocessor controlled blower-based systems that generate Continuous Positive Airway Pressure (CPAP) from 4-20 cmHzO as required to maintain an "air splint" for effective treatment of Obstructive Sleep Apnea (OSA). The system includes the flow generator, patient tubing and a mask (patient interface). For additional humidification, several humidifiers, including the integrated HumidAire 2i, are designed to be compatible with the flow generators.
ResLink is intended to be used with the ResMed S7 Elite and AutoSet Spirit CPAP systems. ResLink provides collection, storage and transfer of treatment data for review by a clinician. In addition to storing treatment data, ResLink can also store pulse oximetry information if a pulse oximeter is connected to it.
ResLink is designed to attach to the flow generator using a docking mechanism. This mechanism allows the device to be electrically connected via a 15-pin expansion port located at the rear of the flow generator. A removable SmartMedia card (SMC) is inserted into ResLink prior to use. Patient data can then be automatically collected when the flow generator is in use. As instructed by the clinician, the patient will remove the SMC and return to the clinic, where the clinician can download the stored data onto a personal computer (PC). The clinician can view the data using AutoScan® software.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Adult patients
Intended User / Care Setting
Home and hospital use.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Design Verification and Validation were performed on the S7 Elite and AutoSet Spirit CPAP Systems with ResLink, in accordance with the risk analysis and product requirements. All tests confirmed the product meets the acceptance criteria. ResMed has determined that the modified design has no impact on the safety and effectiveness of the device. The S7 Elite and AutoSet Spirit CPAP system with ResLink is equivalent to the S7 Elite and AutoSet Spirit CPAP system without ResLink.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 868.5905 Noncontinuous ventilator (IPPB).
(a)
Identification. A noncontinuous ventilator (intermittent positive pressure breathing-IPPB) is a device intended to deliver intermittently an aerosol to a patient's lungs or to assist a patient's breathing.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image shows the text "K024191" in a handwritten style. Below this, the word "Sponsor:" is written, followed by the word "ResMed" in a slightly bolder font. The text suggests that ResMed is the sponsor of something, possibly related to the number above.
510(k) SUMMARY— S7™ Elite and AutoSet® Spirit™ CPAP Systems with ResLink™
| Date Prepared | December 17th, 2002 |
|---|---|
| Official Contact | David D'Cruz |
| VP Regulatory Affairs | |
| ResMed Ltd | |
| 97 Waterloo Road | |
| North Ryde, NSW 2113 | |
| Australia | |
| Tel: +61 (2) 9886 5000 | |
| Fax: +61 (2) 9878 5517 | |
| Classification Reference | 21 CFR 868.5905 |
| Product Code | BZD - Non-Continuous Ventilator |
| Common/Usual Name | CPAP System |
| Proprietary Name | S7™ Elite and AutoSet® Spirit™ CPAP Systems with |
| ResLink™ | |
| Predicate Device(s) | ResMed, S7™ Elite CPAP System (K013909) |
| ResMed, AutoSet® Spirit™ CPAP System (K013843) | |
| Reason for submission | Modified design; additional accessories |
| Indications for Use | The S7™ Elite and AUTOSET® SPIRIT™ CPAP System is |
| indicated for the treatment of Obstructive Sleep Apnea | |
| (OSA) in adult patients. The optional integrated humidifier | |
| (HUMIDAIRE® 2i™) is indicated for the humidification and | |
| warming of air from the S7™ Elite or AUTOSET® SPIRIT™ | |
| flow generator device. The S7™ Elite and AUTOSET® | |
| SPIRIT™ CPAP System and HUMIDAIRE® 2i™ are for home | |
| and hospital use. |
1
Device Description
The S7 Elite (K013909) and AutoSet Spirit (K013843) CPAP Systems are microprocessor controlled blower-based systems that generate Continuous Positive Airway Pressure (CPAP) from 4-20 cmHzO as required to maintain an "air splint" for effective treatment of Obstructive Sleep Apnea (OSA). The system includes the flow generator, patient tubing and a mask (patient interface). For additional humidification, several humidifiers, including the integrated HumidAire 2i, are designed to be compatible with the flow generators.
ResLink is intended to be used with the ResMed S7 Elite and AutoSet Spirit CPAP systems. ResLink provides collection, storage and transfer of treatment data for review by a clinician. In addition to storing treatment data, ResLink can also store pulse oximetry information if a pulse oximeter is connected to it.
ResLink is designed to attach to the flow generator using a docking mechanism. This mechanism allows the device to be electrically connected via a 15-pin expansion port located at the rear of the flow generator. A removable SmartMedia card (SMC) is inserted into ResLink prior to use. Patient data can then be automatically collected when the flow generator is in use. As instructed by the clinician, the patient will remove the SMC and return to the clinic, where the clinician can download the stored data onto a personal computer (PC). The clinician can view the data using AutoScan® software.
Device Modification
Modifications to the S7 Elite and AutoSet Spirit CPAP Systems consist of the following:
- Inclusion of ResLink as an accessory to the cleared S7 Elite and AutoSet Spirit CPAP ට systems, which provides additional memory and allows for the collection, storage and transfer of:
- o Data already stored in the flow generators,
- Data, including pressure and leak, collected by the flow generator at a higher o sampling rate than the data that is stored in the predicate flow generator, and
- Additional data, including minute ventilation, snore index, flattening index, SpOz, o and pulse rate. (Pulse oximetry data is recorded through a separate port in ResLink using a Nonin pulse oximeter.); and
- വ Updated S7 Elite and AutoSet Spirit software from SX116-0203 to SX116-0302 to enable the flow generator and ResLink to communicate and to provide additional display messages on the flow generator LCD to provide feedback to the user on the correct connection and use of ResLink.
Substantial Equivalence
The modified device has the following similarities to the previously cleared predicate devices:
- ם Same Intended Use
- a Same Operating Principle
- ロ Similar Technologies
- Similar Manufacturing Process ប
Design Verification and Validation were performed on the S7 Elite and AutoSet Spirit CPAP Systems with ResLink, in accordance with the risk analysis and product requirements. All tests confirmed the product meets the acceptance criteria. ResMed has determined that the modified design has no impact on the safety and effectiveness of the device. The S7 Elite and AutoSet Spirit CPAP system with ResLink is equivalent to the S7 Elite and AutoSet Spirit CPAP system without ResLink.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol featuring three abstract human profiles facing to the right, with flowing lines above them.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 2 2003
Mr. Roger Kotter ResMed Ltd. c/o ResMed Corporation 14040 Danielson Street Poway, CA 92064-6857
Re: K024191
Trade/Device Name: S7 Elite and AutoSet Spirit CPAP with ResLink Regulation Number: 868.5905 Regulation Name: Noncontinuous ventilator (IPPB) Regulatory Class: II Product Code: BZD Dated: April 2, 2003 Received: April 4, 2003
Dear Mr. Kotter:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Mr. Roger Kotter
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4646. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Sivor Rurn
Susan Runner, DDS, MA Interim Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
510(k) Number (if known): ____ KO2419|
S7™ Elite and AutoSet® Spirit™ CPAP Systems with ResLink™ Device Name:
Indications for Use:
The S7™ Elite and AUTOSET® SPIRIT™ CPAP System is indicated for the treatment of Obstructive Sleep Apnea (OSA) in adult patients. The optional integrated humidifier (HUMIDAIRE® 2i™) is indicated for the humidification and warming of air from the S7™ Elite or AUTOSET® SPIRIT™ flow generator device. The S7™ Elite and AUTOSET® SPIRIT™ CPAP System and HUMIDAIRE® 2i™ are for home and hospital use.
(PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH; Office of Device Evaluation (ODE)
(Division Sign-Off)
Division of Anesthesiology, General Hospital,
Infection Control, Dental Devices
| 510(k) Number: | K024191 |
|---|---|
| ---------------- | --------- |
| Prescription Use (Per 21 CFR 801.109) | X OR Over-The-Counter Use |
|---|---|
| --------------------------------------- | ---------------------------------------------------------------------------- |
(Optional Format 1-2-96)